Cipla Ltd.
BSE: 500087 | NSE: CIPLA
Large Cap | Pharmaceuticals & Drugs
1426.80
-11.95 (-0.83%) Cipla - Quaterly Results
Date: 25-01-2023
A minor change in the total revenue was seen in the December 2022 quarter. The total revenue for the quarter stood at Rs. 38994.50 millions against Rs. 38836.00 millions during year ago period.The Net Profit of the company registered a slight decline of -3.92% to Rs. 6785.20 millions from Rs. 7062.20 millions.The company reported a degrowth in operating Profit to 10652.30 millions from 10800.90 millions.
(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202212 | 202112 | % Var | 202212 | 202112 | % Var | 202203 | 202103 | % Var | |
| Sales | 38994.50 | 38836.00 | 0.41 | 112078.50 | 112177.20 | -0.09 | 130917.90 | 113027.10 | 15.83 |
| Other Income | 1271.20 | 730.00 | 74.14 | 3370.80 | 3503.90 | -3.80 | 6667.00 | 2302.80 | 189.52 |
| PBIDT | 10652.30 | 10800.90 | -1.38 | 31936.20 | 34364.80 | -7.07 | 40331.70 | 32976.90 | 22.30 |
| Interest | 68.50 | 55.50 | 23.42 | 165.60 | 211.50 | -21.70 | 269.30 | 450.70 | -40.25 |
| PBDT | 10583.80 | 10745.40 | -1.50 | 31770.60 | 34153.30 | -6.98 | 40062.40 | 32526.20 | 23.17 |
| Depreciation | 1299.60 | 1339.50 | -2.98 | 4134.30 | 3868.90 | 6.86 | 4600.10 | 4686.20 | -1.84 |
| PBT | 9284.20 | 9405.90 | -1.29 | 27636.30 | 30284.40 | -8.74 | 35462.30 | 27840.00 | 27.38 |
| TAX | 2499.00 | 2343.70 | 6.63 | 7359.20 | 7677.60 | -4.15 | 8568.40 | 7393.50 | 15.89 |
| Deferred Tax | 80.20 | -159.10 | -150.41 | -38.30 | -218.20 | -82.45 | -304.00 | -169.20 | 79.67 |
| PAT | 6785.20 | 7062.20 | -3.92 | 20277.10 | 22606.80 | -10.31 | 26893.90 | 20446.50 | 31.53 |
| Equity | 1614.30 | 1613.60 | 0.04 | 1614.30 | 1613.60 | 0.04 | 1613.60 | 1612.90 | 0.04 |
| PBIDTM(%) | 27.32 | 27.81 | -1.78 | 28.49 | 30.63 | -6.99 | 30.81 | 29.18 | 5.59 |